title: Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
abstract: FGF19 is a hormone that regulates bile acid and glucose homeostasis. Progress has been made in identifying cofactors for receptor activation. However, several functions of FGF19 have not yet been fully defined, including the actions of FGF19 on target tissues, its FGF receptor specificity, and the contributions of other cofactors, such as heparin. Here, we explore the requirements for FGF19-FGFR/co-receptor interactions and signaling in detail. We show that betaKlotho was essential for FGF19 interaction with FGFRs 1c, 2c, and 3c, but FGF19 was able to interact directly with FGFR4 in the absence of betaKlotho in a heparin-dependent manner. Further, FGF19 activated FGFR4 signaling in the presence or absence of betaKlotho, but activation of FGFRs 1c, 2c, or 3c was completely betaKlotho dependent. We then generated an FGF19 molecule, FGF19dCTD, which has a deletion of the C-terminal region responsible for betaKlotho interaction. We determined that betaKlotho-dependent FGFR1c, 2c, and 3c interactions and activation were abolished, and betaKlotho-independent FGFR4 activation was preserved; therefore, FGF19dCTD is an FGFR4-specific activator. This unique FGF19 molecule specifically activated FGFR4-dependent signaling in liver and suppressed CYP7A1 expression in vivo, but was unable to activate signaling in adipose where FGFR4 expression is very low. Interestingly, unlike FGF19, treatment of ob/ob mice with FGF19dCTD failed to improve glucose levels and insulin sensitivity. These results suggest that FGF19-regulated liver bile acid metabolism could be independent of its glucose-lowering effect, and direct FGFR activation in adipose tissue may play an important role in the regulation of glucose homeostasis.
authors.affiliation: Amgen Inc, South San Francisco, CA 94080, USA. xinlew@amgen.com
authors.forename: Xinle
authors.initials: X
authors.lastname: Wu
authors.forename: Hongfei
authors.initials: H
authors.lastname: Ge
authors.forename: Bryan
authors.initials: B
authors.lastname: Lemon
authors.forename: Jennifer
authors.initials: J
authors.lastname: Weiszmann
authors.forename: Jamila
authors.initials: J
authors.lastname: Gupte
authors.forename: Nessa
authors.initials: N
authors.lastname: Hawkins
authors.forename: Xiaofan
authors.initials: X
authors.lastname: Li
authors.forename: Jie
authors.initials: J
authors.lastname: Tang
authors.forename: Richard
authors.initials: R
authors.lastname: Lindberg
authors.forename: Yang
authors.initials: Y
authors.lastname: Li
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D002460:Cell Line; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000378:metabolism* / Q000493:pharmacokinetics; D005947:Glucose / Q000378:metabolism* / Q000493:pharmacokinetics; D005951:Glucose Tolerance Test; D000090265:Klotho Proteins; D008099:Liver / Q000378:metabolism; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008820:Mice, Obese; D009765:Obesity / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding; D051496:Receptor, Fibroblast Growth Factor, Type 1 / Q000235:genetics / Q000378:metabolism; D051497:Receptor, Fibroblast Growth Factor, Type 2 / Q000235:genetics / Q000378:metabolism; D051498:Receptor, Fibroblast Growth Factor, Type 3 / Q000235:genetics / Q000378:metabolism; D051499:Receptor, Fibroblast Growth Factor, Type 4 / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014018:Tissue Distribution; D015533:Transcriptional Activation
chemical_list: C418622:Klb protein, mouse; D008565:Membrane Proteins; D005346:Fibroblast Growth Factors; C496349:Fgfr1 protein, mouse; C496366:Fgfr3 protein, mouse; C496372:Fgfr4 protein, mouse; D051496:Receptor, Fibroblast Growth Factor, Type 1; D051497:Receptor, Fibroblast Growth Factor, Type 2; D051498:Receptor, Fibroblast Growth Factor, Type 3; D051499:Receptor, Fibroblast Growth Factor, Type 4; D000090265:Klotho Proteins; D005947:Glucose
references.citation: J Biol Chem. 2007 Sep 14;282(37):26687-26695
references.pmid: 17623664
references.citation: Biochim Biophys Acta. 2009 Jan 1;1790(1):40-8
references.pmid: 18835578
references.citation: Diabetes. 2007 Oct;56(10):2501-10
references.pmid: 17664243
references.citation: Endocrinology. 2004 Jun;145(6):2594-603
references.pmid: 14976145
references.citation: Endocrinology. 2008 Dec;149(12):6018-27
references.pmid: 18687777
references.citation: J Clin Invest. 2005 Aug;115(8):2202-8
references.pmid: 16075061
references.citation: Nature. 2006 Dec 7;444(7120):770-4
references.pmid: 17086194
references.citation: Biochemistry. 2004 Jan 27;43(3):629-40
references.pmid: 14730967
references.citation: J Biol Chem. 2007 Oct 5;282(40):29069-72
references.pmid: 17711860
references.citation: J Biol Chem. 2008 Nov 28;283(48):33304-9
references.pmid: 18829467
references.citation: Proc Natl Acad Sci U S A. 2007 May 1;104(18):7432-7
references.pmid: 17452648
references.citation: Cell Metab. 2005 Oct;2(4):217-25
references.pmid: 16213224
references.citation: Cytokine. 1999 Oct;11(10):729-35
references.pmid: 10525310
references.citation: J Biol Chem. 2009 Apr 24;284(17):11110-20
references.pmid: 19237543
references.citation: Genes Dev. 2003 Jul 1;17(13):1581-91
references.pmid: 12815072
references.citation: Cytokine Growth Factor Rev. 2005 Apr;16(2):221-32
references.pmid: 15863037
references.citation: Mol Cell Biol. 2007 May;27(9):3417-28
references.pmid: 17339340
references.citation: Curr Opin Nephrol Hypertens. 2006 Jul;15(4):437-41
references.pmid: 16775459
references.citation: Endocrinology. 2002 May;143(5):1741-7
references.pmid: 11956156
references.citation: J Biol Chem. 2007 Sep 14;282(37):27277-27284
references.pmid: 17627937